Skip to main content

Table 2 Clinical and nutritional status of patients at baseline

From: Daily consumption of ready-to-use peanut-based therapeutic food increased fat free mass, improved anemic status but has no impact on the zinc status of people living with HIV/AIDS: a randomized controlled trial

 

Groups

 

Control (n = 25)

RUTF (n = 26)

p

Age (y)

42 ± 12

40 ± 12

0.800

Female, % (n)

52 (22)

86 (13)

0.090

HIV-1, % (n)

84 (21)

92 (24)

0.874

ART, % (n)

76 (19)

73 (19)

1.000

CD4 count),

128 ± 148

109 ± 165

0.082

<200 cells/μL, % (n)

84 (19)

81.7 (21)

0.725.

Weight (kg)

51.4 ± 9.8

47.1 ± 9.4

0.121

Height (m)

1.72 ± 0.08

1.66 ± 0.50

0.006

BMI (kg/m2)

17.5 ± 0.6

16.7 ± 0.6

0.711

< 16 kg/m 2 , % (n)

24 (8)

34 (11)

0.886

TBW (kg)

8.1 ± 2.7

7.7 ± 2.8

0.121

FFM (kg)

11.1 ± 0.4

10.6 ± 0.4

0.121

BF (kg)

39.4 ± 1.2

37.8 ± 1.2

0.651

% BF

78.0

78.2

0.789

Zinc (μg/dL)

68.1 ± 29.8

68.7 ± 32.4

0.992

 Zinc deficiency, % (n)

64 (16)

54 (14)

0.765

Hb (μg/dL)

8.5 ± 2.0

8.4 ± 2.2

0.084

 Anemia, % (n)

96 (24)

92 (24)

1.000

Chronic infection, % (n)

32 (8)

31 (8)

1.000

  1. Zinc deficiency: women, PZ <70 g/dL (morning fasting) and PZ < 66 mg/dL (morning nonfasting); men, PZ <74 g/dL (morning fasting) and PZ <70 mg/dL (morning nonfasting)
  2. Anemia: women, Hb <12 μg/dL and men Hb <14 μg/dL
  3. Chronic infection: CRP < 5 mg/L and AGP ≥ 1 g/L